Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Pharmaceutical Research and Manufacturers of America (Phrma)
Headquarters: Washington, DC, United States of America
Website: http://www.phrma.org
Year Founded: 1958
Status: Archived
BioCentury | Feb 20, 2025
Management Tracks
Bourla becomes chair of PhRMA
Plus: Steve Worland named CEO of Atomwise and updates from Ona, Cidara and Biosion
BioCentury | Nov 19, 2024
Politics, Policy & Law
As Congress considers Biosecure, report says WuXi companies low-risk
Rhodium Group report suggests Congress focus on economic rather than military threats from China biotech
BioCentury | Jul 30, 2024
Regulation
FDA tweaks formula to avoid another user-fee spike
Application fee set to increase to $4.3M, would have been $5M using old formula
BioCentury | Mar 1, 2024
Politics, Policy & Law
Another IRA strike against industry
Delaware judge rules against AstraZeneca, focusing attention on upcoming cases
BioCentury | Feb 21, 2024
Management Tracks
Papa succeeds Miller as Emergent’s CEO
Plus: Paratus names Heah as CEO and updates from Jazz, Arvinas, KaliVir, Celcuity, QuidelOrtho, Turnstone and PhRMA
BioCentury | Feb 13, 2024
Politics, Policy & Law
Texas judge impedes IRA suit’s path to Supreme Court
Dismissing PhRMA’s lawsuit could prevent it from appealing to conservative Fifth Circuit
BioCentury | Jan 31, 2024
Politics, Policy & Law
Industry seeking IRA carve-out for some small molecules
Pharmaceutical industry lobbying for bill to extend threshold for price negotiation of genetically targeted drugs
BioCentury | Jan 5, 2024
Politics, Policy & Law
Florida drug importation will have little impact
First state drug import program aimed at voters, not patients
BioCentury | Nov 17, 2023
Politics, Policy & Law
IRA’s unintended consequences include harm to rare disease patients
Advocates, biopharma companies push Congress to revise the law to reduce barriers to orphan drug development
BioCentury | Nov 3, 2023
Politics, Policy & Law
U.S. cites Stelara biosimilar approval in PhRMA IRA case
Justice Dept. says biosimilar will cause deselection before IRA hits Part B prices
Items per page:
1 - 10 of 368